Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Dermitzaki, Eirini ^a   Liapakis, George ^a   Androulidaki, Ariadne ^a   Venihaki, Maria ^a   Melissas, John ^a   Tsatsanis, Christos ^a   Margioris, Andrew N ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CORTAGINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1 STIMULATING AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1A; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2 STIMULATING AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2A; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2B; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2C; CXCL1 CHEMOKINE; HORMONE RECEPTOR STIMULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN I; UROCORTIN II; UROCORTIN III; ADIPOCYTOKINE; CYTOKINE; PRIMER DNA;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DRUG POTENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INFLAMMATION; INTRAABDOMINAL FAT; MALE; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN EXPRESSION; WHITE ADIPOSE TISSUE; 3T3 CELL LINE; ANALYSIS OF VARIANCE; ANIMAL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; WHITE ADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOKINES; ANALYSIS OF VARIANCE; ANIMALS; CELL DIFFERENTIATION; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; UROCORTINS;

EID: 84901358624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097060     Document Type: Article

References (36)

1. Tsatsanis C, Androulidaki A, Alissafi T, Charalampopoulos I, Dermitzaki E, et al. (2006) Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J Immunol 176: 1869-1877. (Pubitemid 43134332)
2. Tsatsanis C, Androulidaki A, Dermitzaki E, Gravanis A, Margioris AN (2007) Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J Cell Physiol 210: 774-783. (Pubitemid 46185047)
3. Charalampopoulos I, Androulidaki A, Minas V, Chatzaki E, Tsatsanis C, et al. (2006) Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells. Neuroendocrinology 84: 49-57. (Pubitemid 44973687)
4. Tsatsanis C, Androulidaki A, Dermitzaki E, Charalampopoulos I, Spiess J, et al. (2005) Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett 579: 4259-4264. (Pubitemid 41116349)
5. Trayhurn P, Wood IS (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33: 1078-1081. (Pubitemid 41659117)
6. Shi H, Song CK, Giordano A, Cinti S, Bartness TJ (2005) Sensory or sympathetic white adipose tissue denervation differentially affects depot growth and cellularity. Am J Physiol Regul Integr Comp Physiol 288: R1028-1037. (Pubitemid 40404180)
7. Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, et al. (2004) Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 89: 965-970. (Pubitemid 38269919)
8. Friedberg M, Zoumakis E, Hiroi N, Bader T, Chrousos GP, et al. (2003) Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. J Clin Endocrinol Metab 88: 385-393. (Pubitemid 36115193)
9. Turner JJ, Foxwell KM, Kanji R, Brenner C, Wood S, et al. Investigation of nuclear factor-kappaB inhibitors and interleukin-10 as regulators of inflammatory signalling in human adipocytes. Clin Exp Immunol 162: 487-493.
10. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, et al. (2000) The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 275: 24255-24263. (Pubitemid 30626513)
11. Adapala VJ, Buhman KK, Ajuwon KM (2011) Novel anti-inflammatory role of SLPI in adipose tissue and its regulation by high fat diet. J Inflamm (Lond) 8: 5.
12. Lira FS, Rosa JC, Pimentel GD, Seelaender M, Damaso AR, et al. (2012) Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-kappaB pathway in 3T3-L1 adipocytes. Cytokine 57: 98-106.
13. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, et al. (1999) A role for preadipocytes as macrophage-like cells. Faseb J 13: 305-312. (Pubitemid 29072407)
14. Dermitzaki E, Gravanis A, Venihaki M, Stournaras C, Margioris AN (2001) Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments. Endocrinology 142: 2022-2031. (Pubitemid 32405961)
15. Gkountelias K, Tselios T, Venihaki M, Deraos G, Lazaridis I, et al. (2009) Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding. Mol Pharmacol 75: 793-800.
16. Pekala PH, Lane MD, Watkins PA, Moss J (1981) On the mechanism of preadipocyte differentiation. Masking of poly(ADP-ribose) synthetase activity during differentiation of 3T3-L1 preadipocytes. J Biol Chem 256: 4871-4876. (Pubitemid 11035341)
17. Hajer GR, van Haeften TW, Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29: 2959-2971.
18. Cani PD, Delzenne NM, Amar J, Burcelin R (2008) Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) 56: 305-309.
19. Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, et al. (2003) Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 278: 9850-9855. (Pubitemid 36800488)
20. Ciardi C, Jenny M, Tschoner A, Ueberall F, Patsch J, et al. (2011) Food additives such as sodium sulphite, sodium benzoate and curcumin inhibit leptin release in lipopolysaccharide-treated murine adipocytes in vitro. Br J Nutr 107: 826-833.
21. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, et al. (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301: 1045-1050. (Pubitemid 36279218)
22. Tomlinson JW, Crabtree N, Clark PM, Holder G, Toogood AA, et al. (2003) Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity. J Clin Endocrinol Metab 88: 2113-2118. (Pubitemid 36549886)
23. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, et al. (2003) Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278: 11888-11896. (Pubitemid 36800160)
24. Hiroi N, Wong ML, Licinio J, Park C, Young M, et al. (2001) Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 6: 540-546. (Pubitemid 32772563)
25. Lafontan M, Berlan M (2003) Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 24: 276-283. (Pubitemid 36725002)
26. Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell ME, et al. (2008) Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 16: 932-937. (Pubitemid 351620468)
27. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56: 1986-1998. (Pubitemid 47195825)
28. Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83: 847-850. (Pubitemid 28496456)
29. Ahima RS (2008) Revisiting leptin's role in obesity and weight loss. J Clin Invest 118: 2380-2383.
30. Vicennati V, Vottero A, Friedman C, Papanicolaou DA (2002) Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord 26: 905-911. (Pubitemid 34756171)
31. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, et al. (1996) Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45: 1435-1438. (Pubitemid 26332910)
32. Rentsch J, Chiesi M (1996) Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 379: 55-59. (Pubitemid 26033925)
33. Fruhbeck G, Jebb SA, Prentice AM (1998) Leptin: physiology and pathophysiology. Clin Physiol 18: 399-419. (Pubitemid 28451466)
34. Sonti G, Ilyin SE, Plata-Salaman CR (1996) Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 270: R1394-1402.
35. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, et al. (1995) Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268: E813-819.
36. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, et al. (1997) Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66: 54-62. (Pubitemid 27271992)